The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 25, 2017
Filed:
Feb. 24, 2015
Applicant:
United Therapeutics Corporation, Silver Spring, MD (US);
Inventor:
Michael Wade, Chapel Hill, NC (US);
Assignee:
United Therapeutics Corporation, Silver Spring, MD (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/56 (2006.01); A61K 31/192 (2006.01); A61K 31/191 (2006.01); A61K 31/201 (2006.01); A61K 31/557 (2006.01); A61K 31/57 (2006.01);
U.S. Cl.
CPC ...
A61K 31/192 (2013.01); A61K 31/191 (2013.01); A61K 31/201 (2013.01); A61K 31/557 (2013.01); A61K 31/57 (2013.01);
Abstract
The present invention describes novel methods for using Treprostinil or its derivative, or a pharmaceutically acceptable salt thereof, for the treatment and/or prevention of ischemic lesions, such as digital ulcers, in subjects with scleroderma (including systemic sclerosis), Buerger's disease, Raynaud's disease, Raynaud's phenomenon and/or other conditions that cause such lesions. The invention also relates to kits for treatment and/or prevention of ischemic lesions, comprising an effective amount of Treprostinil or its derivative, or a pharmaceutically acceptable salt thereof.